Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by María Guadalupe Valverde AguilarfiledCriticalMaría Guadalupe Valverde Aguilar
Priority to MX2013007331ApriorityCriticalpatent/MX2013007331A/en
Publication of MX2013007331ApublicationCriticalpatent/MX2013007331A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Composition of TiO2/Dopamine prepared by the sol-gel method with nanopores containing the dopamine and avoiding oxidation originated by light and air, which would damage and affect the neurotransmitter effect of the same in the brain. The constant release of the dopamine from the composition allows the symptoms of the Parkinson Disease to be controlled.
MX2013007331A2013-06-212013-06-21Composition of tio2/dopamine implanted in the brain of rats for the treatment of hemiparkinsonism.
MX2013007331A
(en)
C6-c18-acylated derivative of hyaluronic acid, method of preparation thereof, nanomicellar composition on its basis, method of preparation thereof and method of preparation stabilized nanomicellar composition, and use thereof
2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5-carboxylic acid [(s)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl]-amide for use in the treatment of pain associated to osteoarthritis.